1. Home
  2. STOK vs RXT Comparison

STOK vs RXT Comparison

Compare STOK & RXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STOK
  • RXT
  • Stock Information
  • Founded
  • STOK 2014
  • RXT 1998
  • Country
  • STOK United States
  • RXT United States
  • Employees
  • STOK N/A
  • RXT N/A
  • Industry
  • STOK Biotechnology: Pharmaceutical Preparations
  • RXT EDP Services
  • Sector
  • STOK Health Care
  • RXT Technology
  • Exchange
  • STOK Nasdaq
  • RXT Nasdaq
  • Market Cap
  • STOK 721.4M
  • RXT 587.7M
  • IPO Year
  • STOK 2019
  • RXT 2020
  • Fundamental
  • Price
  • STOK $11.67
  • RXT $2.44
  • Analyst Decision
  • STOK Strong Buy
  • RXT Hold
  • Analyst Count
  • STOK 7
  • RXT 6
  • Target Price
  • STOK $21.40
  • RXT $2.47
  • AVG Volume (30 Days)
  • STOK 562.4K
  • RXT 728.9K
  • Earning Date
  • STOK 11-05-2024
  • RXT 11-12-2024
  • Dividend Yield
  • STOK N/A
  • RXT N/A
  • EPS Growth
  • STOK N/A
  • RXT N/A
  • EPS
  • STOK N/A
  • RXT N/A
  • Revenue
  • STOK $16,742,999.00
  • RXT $2,771,200,000.00
  • Revenue This Year
  • STOK $103.04
  • RXT N/A
  • Revenue Next Year
  • STOK N/A
  • RXT N/A
  • P/E Ratio
  • STOK N/A
  • RXT N/A
  • Revenue Growth
  • STOK 81.08
  • RXT N/A
  • 52 Week Low
  • STOK $4.09
  • RXT $1.45
  • 52 Week High
  • STOK $17.58
  • RXT $3.41
  • Technical
  • Relative Strength Index (RSI)
  • STOK 41.75
  • RXT 45.13
  • Support Level
  • STOK $11.80
  • RXT $2.47
  • Resistance Level
  • STOK $12.58
  • RXT $2.67
  • Average True Range (ATR)
  • STOK 0.83
  • RXT 0.12
  • MACD
  • STOK -0.06
  • RXT -0.02
  • Stochastic Oscillator
  • STOK 8.32
  • RXT 14.81

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is engaged in addressing the underlying causes of severe diseases by upregulating protein expression with RNA-based medicines. Using its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, it is developing antisense oligonucleotides (ASOs) to selectively restore protein levels. Its first compound, STK-001, is in clinical testing for the treatment of Dravet syndrome, a severe and progressive genetic epilepsy. The company primarily operates in the U.S.

About RXT Rackspace Technology Inc.

Rackspace Technology Inc is an end-to-end, hybrid, multi cloud technology services company. It designs, builds and operates its customers' cloud environments across all technology platforms, irrespective of technology stack or deployment model. The company's solutions include Application Services; Data; Colocation; Cloud; Managed Hosting; Professional Services; and Security & Compliance. It operates in segments namely, Private Cloud, and Public Cloud. It generates revenue through the sale of consumption-based contracts for its service offerings and from the sale of professional services related to designing and building custom solutions.

Share on Social Networks: